Patents by Inventor Siddharth Pandey
Siddharth Pandey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11957815Abstract: An artificial tissue construct for nerve repair and regeneration includes a biocompatible and biodegradable nerve guidance matrix comprising a plurality of biopolymers that include chitosan, gelatin, collagen and hyaluronic acid. A cross-linker includes glutaraldehyde. The nerve guidance matrix is formed as a three-dimensional scaffold polyelectrolyte complex (PEC). A subconfluent and grown monolayer of at least one of human mesenchymal stem cells, mesenchymal stem cells, differentiated Schwann cells and neuronal cells is on the biocompatible and biodegradable nerve guidance matrix for direct implantation or delivery. A method of making the artificial tissue construct is disclosed.Type: GrantFiled: November 12, 2020Date of Patent: April 16, 2024Assignee: DATT LIFE SCIENCES PRIVATE LIMITEDInventors: Rajan Datt, Siddharth Pandey, Poonam Meena, Mukesh Kumar, Nitin Khatri, Rakesh Kumar Nagar
-
Patent number: 11612631Abstract: This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.Type: GrantFiled: June 8, 2021Date of Patent: March 28, 2023Assignee: DATT LIFE SCIENCES PRIVATE LIMITEDInventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Ramadhar Kumar
-
Publication number: 20220016320Abstract: An artificial tissue construct for nerve repair and regeneration includes a biocompatible and biodegradable nerve guidance matrix comprising a plurality of biopolymers that include chitosan, gelatin, collagen and hyaluronic acid. A cross-linker includes glutaraldehyde. The nerve guidance matrix is formed as a three-dimensional scaffold polyelectrolyte complex (PEC). A subconfluent and grown monolayer of at least one of human mesenchymal stem cells, mesenchymal stem cells, differentiated Schwann cells and neuronal cells is on the biocompatible and biodegradable nerve guidance matrix for direct implantation or delivery. A method of making the artificial tissue construct is disclosed.Type: ApplicationFiled: November 12, 2020Publication date: January 20, 2022Inventors: Rajan DATT, Siddharth Pandey, Poonam Meena, Mukesh Kumar, Nitin Khatri, Rakesh Kumar Nagar
-
Patent number: 11126670Abstract: A network device receives credentials of a user of a client device, and receives an enrollment request from the client device, wherein the enrollment request includes a network address of the client device. The network device generates a token comprising the network address and an identifier of the user, encrypts the token, and sends the encrypted token to the client device. The network device receives, when the client device attempts to access a protected resource or a network service, the encrypted token from the client device for authenticating the client device without further requiring the credentials of the user.Type: GrantFiled: May 10, 2017Date of Patent: September 21, 2021Assignee: Verizon Patent and Licensing Inc.Inventors: Siddharth Pandey, Manah M. Khalil, Michael R. Lamison, John J. Christudass, Krishna C. Yendrapalli, Narayanan Kasiviswanathan Shankar, Saikumar Dubagunta, Ping Chu, Maneesha Kalra
-
Patent number: 11058741Abstract: This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phytopharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.Type: GrantFiled: October 10, 2019Date of Patent: July 13, 2021Assignee: DATT LIFE SCIENCES PRIVATE LIMITEDInventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Ramadhar Kumar
-
Patent number: 10561701Abstract: This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.Type: GrantFiled: August 29, 2018Date of Patent: February 18, 2020Assignee: DATT LIFE SCIENCES PRIVATE LIMITEDInventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Ramadhar Kumar
-
Patent number: 10293075Abstract: The invention relates to porous absorbent Composite Material, which may be used e.g. in the form of a plug or tampon, for instance for controlling bleeding, wound closure, prevent tissue adhesion and/or support tissue regeneration. The invention provides a hydrophilic Self-Dispersive, fragmentable and Bio-Absorbable Porous Composite foams, suitable for packing antrum or other cavities of the body, comprising of composite of polymers, which polymer preferably comprises —C(O)—O—; NH2/3+; —OH; —CH2OCH2C(O)O— groups as functional or —CH—O— (e.g. C2H4O; C6H10O5; C6H8O6); —CH—N—O— (e.g. C8H13NO5); O—C—C— (e.g. O—CH2-CH2); —C(O)N— groups in the backbone of the polymers e.g. gelatin, chitosan, collagen, alginate, polyvinyl alcohol, polyethylene glycol, keratin, cellulose.Type: GrantFiled: March 25, 2016Date of Patent: May 21, 2019Assignee: DATT LIFE SCIENCES PRIVATE LIMITEDInventors: Rajan Datt, Ramadhar Kumar, Siddharth Pandey, Pallavi Shrivastava
-
Publication number: 20180369315Abstract: This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.Type: ApplicationFiled: August 29, 2018Publication date: December 27, 2018Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Ramadhar Kumar
-
Publication number: 20180353655Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated form mesenchymal stem cells in vitro and keratinocytes differentiated form mesenchymal stem cells in vitro) in vitro for continued periods of time. In the present invention, mesenchymal stem cells (MSCs) derived from bone marrow or umbilical cord are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells. The developed bioengineered tissue constructs provide the support, growth factors and essential cytokines for wound healing. Developed tissue construct useful in the treatment of burns wound, diabetic foot ulcer wound and type of chronic skin wounds. It is helpful in healing and regeneration of skin tissue.Type: ApplicationFiled: August 22, 2018Publication date: December 13, 2018Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Supriya Srivastava
-
Patent number: 10149924Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated form mesenchymal stem cells in vitro and keratinocytes differentiated form mesenchymal stem cells in vitro) in vitro for continued periods of time. In the present invention, mesenchymal stem cells (MSCs) derived from bone marrow or umbilical cord are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells. The developed bioengineered tissue constructs provide the support, growth factors and essential cytokines for wound healing. Developed tissue construct useful in the treatment of burns wound, diabetic foot ulcer wound and type of chronic skin wounds. It is helpful in healing and regeneration of skin tissue.Type: GrantFiled: August 22, 2018Date of Patent: December 11, 2018Assignees: DATT MEDIPRODUCTS LIMITED, DATT LIFE SCIENCE PVT. LTD.Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Supriya Srivastava
-
Publication number: 20180332016Abstract: A network device receives credentials of a user of a client device, and receives an enrollment request from the client device, wherein the enrollment request includes a network address of the client device. The network device generates a token comprising the network address and an identifier of the user, encrypts the token, and sends the encrypted token to the client device. The network device receives, when the client device attempts to access a protected resource or a network service, the encrypted token from the client device for authenticating the client device without further requiring the credentials of the user.Type: ApplicationFiled: May 10, 2017Publication date: November 15, 2018Inventors: Siddharth Pandey, Manah M. Khalil, Michael R. Lamison, John J. Christudass, Krishna C. Yendrapalli, Narayanan Kasiviswanathan Shankar, Saikumar Dubagunta, Ping Chu, Maneesha Kalra
-
Patent number: 10098986Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated form mesenchymal stem cells in vitro and keratinocytes differentiated form mesenchymal stem cells in vitro) in vitro for continued periods of time. In the present invention, mesenchymal stem cells (MSCs) derived from bone marrow or umbilical cord are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells. The developed bioengineered tissue constructs provide the support, growth factors and essential cytokines for wound healing. Developed tissue construct useful in the treatment of burns wound, diabetic foot ulcer wound and type of chronic skin wounds. It is helpful in healing and regeneration of skin tissue.Type: GrantFiled: June 15, 2018Date of Patent: October 16, 2018Assignees: DATT MEDIPRODUCTS LIMITED, DATT LIFE SCIENCE PVT. LTD.Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Supriya Srivastava
-
Publication number: 20180289865Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated form mesenchymal stem cells in vitro and keratinocytes differentiated form mesenchymal stem cells in vitro) in vitro for continued periods of time. In the present invention, mesenchymal stem cells (MSCs) derived from bone marrow or umbilical cord are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells. The developed bioengineered tissue constructs provide the support, growth factors and essential cytokines for wound healing. Developed tissue construct useful in the treatment of burns wound, diabetic foot ulcer wound and type of chronic skin wounds. It is helpful in healing and regeneration of skin tissue.Type: ApplicationFiled: June 15, 2018Publication date: October 11, 2018Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Supriya Srivastava
-
Patent number: 10076552Abstract: This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.Type: GrantFiled: December 20, 2016Date of Patent: September 18, 2018Assignee: DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD.Inventors: Rajan Datt, Ramadhar Kumar, Siddharth Pandey, Pallavi Shrivastava
-
Patent number: 10021673Abstract: A wireless communication device (UE) conducting wireless communications according to a specified radio access technology (RAT) in a first communications band belonging to a first network may be required to switch to a different communications band due to network restrictions and/or radio link failure. The UE may therefore perform a system scan identifying other communications bands associated with the first RAT and available at the present location of the UE. The UE may identify whether the other communications bands include preferred communications bands belonging to the first network, support a service associated with the wireless communications of the UE, and have an energy level higher than a specified threshold. If one or more preferred communications bands are present, the UE may switch communications from the first communications band to one of the preferred communications bands, even if it doesn't have the highest energy level among all the other communications bands.Type: GrantFiled: March 25, 2016Date of Patent: July 10, 2018Assignee: Apple Inc.Inventors: Alosious Pradeep Prabhakar, Jose A. Castelo Vega, Siddharth Pandey, Aditya A. Marawar, Rafael L. Rivera-Barreto
-
Patent number: 10004830Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated form mesenchymal stem cells in vitro and keratinocytes differentiated form mesenchymal stem cells in vitro) in vitro for continued periods of time. In the present invention, mesenchymal stem cells (MSCs) derived from bone marrow or umbilical cord are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells. The developed bioengineered tissue constructs provide the support, growth factors and essential cytokines for wound healing. Developed tissue construct useful in the treatment of burns wound, diabetic foot ulcer wound and type of chronic skin wounds. It is helpful in healing and regeneration of skin tissue.Type: GrantFiled: April 12, 2017Date of Patent: June 26, 2018Assignee: DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD.Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Supriya Srivastava
-
Patent number: 9998639Abstract: A device for conducting scientific experiments in space has a housing having dimensions of about 100×100×150 mm or smaller. Within the housing is an electronic processor, a camera, and a chamber for containing living or non-living test subjects. A mirror is positioned next to the chamber so that the camera lens can view both a face of the chamber, and the mirror, which reflects a side of the chamber. The chamber can additionally include sensors and a fan controlled by the processor to change conditions within the housing based upon sensor data.Type: GrantFiled: September 16, 2016Date of Patent: June 12, 2018Assignee: The United States of America as Represented by the Administrator of the NASAInventors: Sharmila Bhattacharya, Terry Clay Lusby, Chetan Angadi, Siddharth Pandey
-
Publication number: 20180147324Abstract: The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated form mesenchymal stem cells in vitro and keratinocytes differentiated form mesenchymal stem cells in vitro) in vitro for continued periods of time. In the present invention, mesenchymal stem cells (MSCs) derived from bone marrow or umbilical cord are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells. The developed bioengineered tissue constructs provide the support, growth factors and essential cytokines for wound healing. Developed tissue construct useful in the treatment of burns wound, diabetic foot ulcer wound and type of chronic skin wounds. It is helpful in healing and regeneration of skin tissue.Type: ApplicationFiled: April 12, 2017Publication date: May 31, 2018Inventors: Rajan Datt, Siddharth Pandey, Pallavi Shrivastava, Supriya Srivastava
-
Publication number: 20170280422Abstract: A wireless communication device (UE) conducting wireless communications according to a specified radio access technology (RAT) in a first communications band belonging to a first network may be required to switch to a different communications band due to network restrictions and/or radio link failure. The UE may therefore perform a system scan identifying other communications bands associated with the first RAT and available at the present location of the UE. The UE may identify whether the other communications bands include preferred communications bands belonging to the first network, support a service associated with the wireless communications of the UE, and have an energy level higher than a specified threshold. If one or more preferred communications bands are present, the UE may switch communications from the first communications band to one of the preferred communications bands, even if it doesn't have the highest energy level among all the other communications bands.Type: ApplicationFiled: March 25, 2016Publication date: September 28, 2017Inventors: Alosious Pradeep Prabhakar, Jose A. Castelo Vega, Siddharth Pandey, Aditya A. Marawar, Rafael L. Rivera-Barreto
-
Patent number: 9741031Abstract: A portable device includes a data capture unit and a wireless communication circuit in communication with a control circuit. The data capture unit is configured to receive product information from a product identifier. The wireless communication circuit is configured to communicate with a vendor server storing an electronic catalog that includes a product associated with the product information.Type: GrantFiled: December 11, 2008Date of Patent: August 22, 2017Assignee: Verizon Patent and Licensing Inc.Inventor: Siddharth Pandey